the role of tyrosine kinase inhibitors and mtor inhibitors
Published 9 years ago • 4.2K plays • Length 41:21Download video MP4
Download video MP3
Similar videos
-
6:08
role of mtor inhibition in kidney cancer
-
4:58
hcc whiteboard #2: the mechanisms of action of tyrosine kinase inhibitors
-
4:49
frontline tki strategies in kidney cancer
-
1:44
dr. figlin discusses sequencing mtor inhibitors and tkis in rcc
-
6:40
perspectives on sequencing in metastatic renal cell carcinoma
-
4:20
tyrosine kinase inhibitors (tkis) - imatinib (gleevec) - pharmacology - cml and all
-
1:27
dr. grigg on frontline tyrosine kinase inhibitors in rcc
-
1:37
inhibition of abl tyrosine kinases shows potential for metastatic cancer treatment
-
2:02
tki and checkpoint inhibitor combinations for kidney cancer: the immotion151 trial
-
5:25
bruton tyrosine kinase inhibitors
-
1:35
micrornas' role in tyrosine kinase inhibitor resistance and their potential as indicators
-
4:19
role of pd-l1 status in mrcc
-
1:49
role of tyrosine kinases in bladder cancer progression
-
8:27
checkpoint inhibition in renal cell carcinoma
-
1:10
immuno-oncology agents plus tyrosine kinase inhibitors?
-
2:08
for physicians: vegf tyrosine kinase inhibitor treatment risks | dana-farber cancer institute
-
23:42
dr. ruether - current medical treatments for kidney cancer
-
6:22
mtor/tki combination therapy in kidney cancer
-
1:50
the pi3k signaling pathway